Is Biogen’s Research Pipeline a Reason to Invest?
Biogen Inc. (NASDAQ:BIIB) has been a laggard this year with its share price plunging 41% year-to-date against the broader market’s 26.6% gain. The …
CNS Pharmaceuticals Inc
Will Acadia Pharmaceuticals Stock Recover?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at the forefront of neuroscience developing therapies for central nervous system conditions. The company primarily …
1 Gene Therapy Biotech Grew 1,296%
Biotech firms can be a risky bet at the best of times, but when they do pay off they deliver the goods in a way that few other businesses can match. Take …